The versatility of the αβ T-cell antigen receptor

Protein Science

Volumn 23, Issue 3, 2014, Pages 260-272

  Bhati, Mugdha ^a   Cole, David K ^b   McCluskey, James ^c   Sewell, Andrew K ^b   Rossjohn, Jamie ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen presenting molecules; Immune system; Structures; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; VITAMIN B GROUP;

ANTIGEN BINDING; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; HLA SYSTEM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTIGEN PRESENTING MOLECULES; IMMUNE SYSTEM; STRUCTURES; T-CELL RECEPTOR;

ANIMALS; COMPLEMENTARITY DETERMINING REGIONS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, MOLECULAR; PEPTIDES; POLYMORPHISM, GENETIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 84900459943     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2412     Document Type: Review

References (129)

1. Turner SJ, Doherty PC, McCluskey J, Rossjohn J( 2006) Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 6:883-894
2. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-141
3. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA (1996) An ab T-cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209-219
4. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK (2012) Structural and biophysical determinants of ab T-cell antigen recognition. Immunology 135:9-18
5. Berry R, Chen Z, McCluskey J, Rossjohn J (2011) Insight into the basis of autonomous immunoreceptor activation. Trends Immunol 32:165-170
6. Pang SS, Berry R, Chen Z, Kjer-Nielsen L, Perugini MA, King GF, Wang C, Chew SH, La Gruta NL, Williams NK, Beddoe T, Tiganis T, Cowieson NP, Godfrey DI, Purcell AW, Wilce MCJ, McCluskey J, Rossjohn J (2010) The structural basis for autonomous dimerization of the pre-T-cell antigen receptor. Nature 467:844-848
7. Bharadwaj M, Illing P, Theodossis A, Purcell AW, Rossjohn J, McCluskey J (2012) Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu Rec Pharmacol Toxicol 52:401-431
8. Archbold JK, Macdonald WA, Burrows SR, Rossjohn J, McCluskey J (2008) T-cell allorecognition: A case of mistaken identity or déjá vu? Trends Immunol 29:220-226
9. Yin Y, Li Y, Mariuzza RA (2012) Structural basis for self-recognition by autoimmune T-cell receptors. Immunol Rev 250:32-48
10. Eckle SBG, Turner SJ, Rossjohn J, McCluskey J( 2013) Predisposed ab T-cell antigen receptor recognition of MHC and MHC-I like molecules? Curr Opin Immunol 25:653-659
11. Adams EJ, Luoma AM (2013) The adaptable major histocompatibility complex (MHC) fold: Structure and function of nonclassical and MHC Class I-like molecules. Annu Rev Immunol 31:529-561
12. Clements CS, Dunstone MA, Macdonald WA, McCluskey J, Rossjohn J (2006) Specificity on a knifeedge: The ab T cell receptor. Curr Opin Struct Biol 16: 787-795
13. Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL, van Zuylen WJ, Purcell AW, Kjer- Nielsen L, McCluskey J, Burrows SR, Rossjohn J( 2005) High resolution structures of highly bulged viral epitopes bound to major histocompatiblity complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 280: 23900-23909
14. Wang XX, Li Y, Yin Y, Mo M, Wang Q, Gao W, Wang L, Mariuzza RA (2011) Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex. Proc Natl Acad Sci U S A 108:15960-15965
15. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24:419-466
16. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2- peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A 89:3429-3433
17. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221
18. Van Der Merwe PA, Davis SJ (2003) Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 21:659-684
19. Burrows SR, Rossjohn J, McCluskey J (2006) Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol 27:11-16
20. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, Gorman JJ, Clements CS, Kjer-Nielsen L, Koelle DM, Burrows SR, Tait BD, Holdsworth R, Brooks AG, Lovrecz GO, Lu L, Rossjohn J, McCluskey J (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 198:679-691
21. Zernich D, Purcell AW, Macdonald WA, Kjer-Nielsen L, Ely LK, Laham N, Crockford T, Mifsud NA, Bharadwaj M, Chang L, Tait BD, Holdsworth R, Brooks AG, Bottomley SP, Beddoe T, Peh CA, Rossjohn J, McCluskey J (2004) Nature HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med 200:13-24
22. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J (2012) A structural voyage toward an understanding of the MHC-I-restricted immune response: Lessons learned and much to be learned. Immunol Rev 250:61-81
23. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39
24. Henderson KN, Tye-Din JA, Reid HH, Chen Z, Borg NA, Beissbarth T, Tatham A, Mannering SI, Purcell AW, Dudek NL, van Heel DA, McCluskey J, Rossjohn J, Anderson RP (2007) A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27:23-34
25. Broughton SE, Petersen J, Theodossis A, Scally SW, Loh KL, Thompson A, van Bergen J, Kooy-Winkelaar Y, Henderson KN, Beddoe T, Tye-Din JA, Mannering SI, Purcell AW, McCluskey J, Anderson RP, Koning F, Reid HH, Rossjohn J (2012) Biased T cell receptor usage directed against human leukocyte antigen DQ8- restricted gliadin peptides is associated with celiac disease. Immunity 37:611-621
26. Cole DK, Gallagher K, Lemercier B, Holland CJ, Junaid S, Hindley JP, Wynn KK, Gostick E, Sewell AK, Gallimore AM, Ladell K, Price DA, Gougeon ML, Godkin A (2012) Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4(1) T-cell repertoire selection. Nat Commun 3:665
27. Holland CJ, Cole DK, Godkin A (2013) Re-directing CD4(1) T cell responses with the flanking residues of MHC class II-bound peptides: The core is not enough. Front Immunol 4:172
28. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL (1993) Specificity and promiscuity among naturally processed peptides bound to HLADR alleles. J Exp Med 178:27-47
29. Vignali DA, Urban RG, Chicz RM, Strominger JL( 1993) Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur J Immunol 23:1602-1607
30. Godkin AJ, Smith KJ, Willis A, Tejada-Simon MV, Zhang J, Elliott T, Hill AV (2001) Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol 166:6720-6727
31. Godkin AJ, Davenport MP, Willis A, Jewell DP, Hill AV (1998) Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. J Immunol 161:850-858
32. Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, Price DA, Gao GF, Sewell AK, Jakobsen BK (2007) Human TCR-binding affinity is governed by MHC class restriction. J Immunol 178:5727-5734
33. Trowsdale J (2005) HLA genomics in the third millenium. Curr Opin Immunol 17:498-504
34. Robinson J, Waller MJ, Fail SC, McWilliam H, Lopez R, Parham P, Marsh SG (2009) The IMGT/HLA database. Nucleic Acids Res 37:D1013-D1017
35. Ely LK, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2008) T-cells behaving badly: Structural insights into alloreactivity and autoimmunity. Curr Opin Immunol 20:575-580
36. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A, De Luca A, Easterbrook P, Gunthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM, Martinson JJ, Detels R, Margolick JB, Jacobson LP, Descombes P, Antonarakis SE, Beckmann JS, O?Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Feng S, Telenti A, Goldstein DB (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: E1000791
37. Matthews PC, Koyanagi M, Kloverpris HN, Harndahl M, Stryhn A, Akahoshi T, Gatanaga H, Oka S, Juarez Molina C, Valenzuela Ponce H, Avila Rios S, Cole D, Carlson J, Payne RP, Ogwu A, Bere A, Ndung?u T, Gounder K, Chen F, Riddell L, Luzzi G, Shapiro R, Brander C, Walker B, Sewell AK, Reyes Teran G, Heckerman D, Hunter E, Buus S, Takiguchi M, Goulder PJ (2012) Differential clade-specific HLAB. * 3501 association with HIV-1 diseases outcome is linked to immunogenicity of a single Gag epitope. J Virol 86:12643-12654
38. Carlson JM, Listgarten J, Pfeifer N, Tan V, Kadie C, Walker BD, Ndung?u T, Shapiro R, Frater J, Brumme ZL, Goulder PJ, Heckerman D (2012) Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J Virol 86:5230-5243
39. Stewart-Jones GB, Simpson P, Anton Van Der Merwe P, Easterbrook P, McMichael AJ, Rowland-Jones SL, Jones EY, Gillespie GM (2012) Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. Proc Natl Acad Sci U S A 109:E3483-E3492
40. Luz JG, Huang M, Garcia KC, Rudolph MG, Apostolopoulos V, Teyton L, Wilson IA (2002) Structural comparison of allogenic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: A buried alloreactive mutation subtly alters peptide presentation substantially increasing Vb interactions. J Exp Med 195:1175-1186
41. Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, Sullivan LC, Kjer-Nielsen L, Brennan RM, Burrows JM, Neller MA, Khanna R, Purcell AW, Brooks AG, McCluskey J, Rossjohn J, Burrows SR (2010) Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exper Med 207:1555-1567
42. Trowsdale J (2011) The MHC, disease and selection. Immunol Lett 137:1-8
43. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486: 554-558
44. Illing PT, Vivian JP, Purcell AW, Rossjohn J, McCluskey J (2013) Human leukocyte antigenassociated drug hypersensitivity. Curr Opin Immunol 25:81-89
45. Gras S, Saulquin X, Reiser JB, Debeaupuis E, Echasserieau K, Kissenpfennig A, Legoux F, Chouquet A, Le Gorrec M, Machillot P, Neveu B, Thielens N, Malissen B, Bonneville M, Housset D( 2009) Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J Immunol 183:430-437
46. Borbulevych OY, Piepenbrink KH, Gloor BE, Scott DR, Sommese RF, Cole DK, Sewell AK, Baker BM( 2009) T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31:885-896
47. Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS, Bharadwaj M, Kjer-Nielsen L, Saunders PM, Wilce MC, Crawford F, Stadinsky B, Jackson D, Brooks AG, Purcell AW, Kappler JW, Burrows SR, Rossjohn J, McCluskey J (2009) T cell allorecognition via molecular mimicry. Immunity 31:897-908
48. Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, Sullivan LC, Kjer-Nielsen L, Brennan RM, Burrows JM, Neller MA, Khanna R, Purcell AW, Brooks AG, McCluskey J, Rossjohn J, Burrows SR (2010) Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exp Med 207:1555-1567
49. Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC (1998) Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403-411
50. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR, McCluskey J, Rossjohn J( 2003) A structural basis for the selection of dominant ab T cell receptors in antiviral immunity. Immunity 18:53-64
51. Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, Van Der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V (2005) Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med 201:1243-1255
52. Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY (2003) A structural basis for immunodominant human T cell receptor recognition. Nat Immunol 4:657-663
53. Tynan FE, Reid HH, Kjer-Nielsen L, Miles JJ, Wilce MC, Kostenko L, Borg NA, Williamson NA, Beddoe T, Purcell AW, Burrows SR, McCluskey J, Rossjohn J( 2007) A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol 8:268-276
54. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J (2005) T cell receptor recognition of a super-bulged major histocompatibility complex class I-bound peptide. Nat Immunol 6:1114-1122
55. Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, Bell MJ, Brennan RM, Beddoe T, Wilce MC, Clements CS, Purcell AW, McCluskey J, Burrows SR, Rossjohn J( 2009) Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med 206:209-219
56. Miles JJ, Bulek AM, Cole DK, Gostick E, Schauenburg AJ, Dolton G, Venturi V, Davenport MP, Tan MP, Burrows SR, Wooldridge L, Price DA, Rizkallah PJ, Sewell AK (2010) Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in epstein-barr virus infection. PLoS Pathog 6:e1001198
57. Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ (2003) A correlation between TCR Va docking on MHC and CD8 dependence: Implications for T cell selection. Immunity 19:595-606
58. Gras S, Burrows SR, Kjer-Nielsen L, Clements CS, Liu YC, Sullivan LC, Bell MJ, Brooks AG, Purcell AW, McCluskey J, Rossjohn J (2009) The shaping of T cell receptor recognition by self-tolerance. Immunity 30:193-203
59. Cole DK, Yuan F, Rizkallah PJ, Miles JJ, Gostick E, Price DA, Gao GF, Jakobsen BK, Sewell AK (2009) Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem 284:27281-27289
60. Bulek AM, Cole DK, Skowera A, Dolton G, Gras S, Madura F, Fuller A, Miles JJ, Gostick E, Price DA, Drijfhout JW, Knight RR, Huang GC, Lissin N, Molloy PE, Wooldridge L, Jakobsen BK, Rossjohn J, Peakman M, Rizkallah PJ, Sewell AK (2012) Structural basis for the killing of human b cells by CD8(1) T cells in type 1 diabetes. Nat Immunol 13:283-289
61. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J (2012) A structural voyage toward an understanding of the MHC-I-restricted immune response: Lessons learned and much to be learned. Immunol Rev 250:61-81
62. Ely LK, Beddoe T, Clements CS, Matthews JM, Purcell AW, Kjer-Nielsen L, McCluskey J, Rossjohn J( 2006) Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. Proc Natl Acad Sci U S A 103:6641-6646
63. Willcox BE, Gao GF, Wyer JR, Ladbury JE, Bell JI, Jakobsen BK, Van Der Merwe PA (1999) TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10:357-365
64. Garcia KC, Adams JJ, Feng D, Ely LK (2009) The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol 10:143-147
65. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW (2008) Evolutionarily conserved amino acids that control TCR-HMC interaction. Annu Rev Immunol 26: 171-203
66. Armstrong KM, Insaidoo FK, Baker BM (2008) Thermodynamics of T-cell receptor-peptide/MHC interactions: Progress and opportunities. J Mol Recog 21: 275-287
67. Baker BM, Scott DR, Blevins SJ, Hawse WF (2012) Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Immunol Rev 250:10-31
68. Borg NA, Ely LK, Beddoe T, Macdonald WA, Reid HH, Clements CS, Purcell AW, Kjer-Nielsen L, Miles JJ, Burrows SR, McCluskey J, Rossjohn J (2005) The CDR3 regions of an immunodominant T cell receptor dictate the energetic landscape of peptide-MHC recognition. Nat Immunol 6:171-180
69. Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, Miles JJ, Williamson NA, Green KJ, Tellam J, Kjer-Nielsen L, McCluskey J, Rossjohn J, Burrows SR (2005) The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 202:1249-1260
70. Reiser JB, Gregoire C, Darnault C, Mosser T, Guimezanes A, Schmitt-Verhulst AM, Fontecilla- Camps JC, Mazza G, Malissen B, Housset D (2002) A T cell receptor CDR3b loop undergoes conformatoinal changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16:345-354
71. Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA (1998) Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166-1172
72. Sewell AK (2012) Why must T cells be cross-reactive? Nat Rev Immunol 12:669-677
73. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, Dolton G, Clement M, Llewellyn-Lacey S, Price DA, Peakman M, Sewell AK (2012) A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 287:1168-1177
74. Mason D (1998) A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 19:395-404
75. Gras S, Wilmann PG, Chen Z, Halim H, Liu YC, Kjer- Nielsen L, Purcell AW, Burrows SR, McCluskey J, Rossjohn J (2012) A structural basis for varied abTCR usage against an immunodominant EBV antigen restrictured to a HLA-B8 molecule. J Immunol 188: 311-321
76. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J (2011) The structural bases of direct Tcell allorecognition: Implications for T-cell-mediated transplant rejection. Immunol Cell Biol 89:388-395
77. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J (2011) The structural bases of direct Tcell allorecognition: Implications for T-cell-mediated transplant rejection. Immunol Cell Biol 89:388-395
78. Cole DK, Miles KM, Madura F, Holland CJ, Schauenburg AJA, Godkin AJ, Bulek AM, Fuller A, Akpovwa HJE, Pymm PG, Liddy N, Sami M, Li Y, Rizkallah PJ, Jakobsen BK, Sewell AK (2013) TCRpeptide specificity overrides affinity enhancing TCRMHC interactions. J Biol Chem
79. Madura F, Rizkallah PJ, Miles KM, Holland CJ, Bulek AM, Fuller A, Schauenburg AJ, Miles JJ, Liddy N, Sami M, Li Y, Hossain M, Baker BM, Jakobsen BK, Sewell AK, Cole DK (2013) T-cell receptor specificity maintained by altered thermodynamics. J Biol Chem 288:18766-18775
80. Zajonc DM, Wilson IA (2007) Architecture of CD1 proteins. Curr Top Microbiol Immunol 314:27-50
81. Moody DB, Zajonc DM, Wilson IA (2005) Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 5: 387-399
82. Gadola SD, Zaccai NR, Harlos K, Shepherd D, Castro- Palomino JC, Ritter G, Schmidt RR, Jones EY, Cerundolo V (2002) Structure of human CD1b with bound ligands at 2.3 Å a maze for alkyl chains. Nat Immunol 3:721-726
83. Scharf L, Li N-S, Hawk AJ, Garzon D, Zhang T, Fox LM, Kazen AR, Shah S, Haddadian EJ, Gumperz JE, Saghatelian A, Faraldo-Gomez JD, Meredith SC, Piccirilli JA, Adams EJ (2010) The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 33:853-862
84. Zajonc DM, Elsliger MA, Teyton L, Wilson IA (2003) Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å . Nat Immunol 4: 808-815
85. Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, Ritter G, Fersht AR, Besra GS, Schmidt RR, Jones EY, Cerundolo V (2005) The crystal structure of human CD1d with and without a-galactosylceramide. Nat Immunol 6:819-826
86. Zajonc DM, Cantu C 3rd, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA, Teyton L (2005) Structure and function of a potent agonist for the semiinvariant natural killer T cell receptor. Nat Immunol 6:810-818
87. Garcia-Alles LF, Giacometti G, Versluis C, Maveyraud L, de Paepe D, Guiard J, Tranier S, Gilleron M, Prandi J, Hanau D, Heck AJR, Mori L, De Libero G, Puzo G, Mourey L, de la Salle H (2011) Crystal structure of human CD1e reveals a groove suited for lipidexchange processes. Proc Natl Acad Sci U S A 108: 13230-13235
88. Girardi E, Zajonc DM (2012) Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Immunol Rev 250:167-179
89. Godfrey DI, Pellicci DG, Patel O, Kjer-Nielsen L, McCluskey J, Rossjohn J (2010) Antigen recognition by CD1d-restricted NKT T cell receptors. Semin Immunol 22:61-67
90. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI( 2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 12:845-857
91. Patel O, Pellicci DG, Gras S, Sandoval-Romero ML, Uldrich AP, Mallevaey T, Clarke AJ, Le Nours J, Theodossis A, Cardell SL, Gapin L, Godfrey DI, Rossjohn J (2012) Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. Nat Immunol 13:857-863
92. Girardi E, Maricic I, Wang J, Mac T-T, Iyer P, Kumar V, Zajonc DM (2012) Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat Immunol 13: 851-856
93. Giabbai B, Sidobre S, Crispin MD, Sanchez-Ruiz Y, Bachi A, Kronenberg M, Wilson IA, Degano M (2005) Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: A molecular basis for NKT cell activation. J Immunol 175:977-984
94. Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, Ritter G, Fersht AR, Besra GS, Schmidt RR, Jones EY, Cerundolo V (2005) The crystal structure of human CD1d with and without a-galactosylceramide. Nat Immunol 6:819-826
95. Zajonc DM, Maricic I, Wu D, Halder R, Roy K, Wong CH, Kumar V, Wilson IA (2005) Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 202:1517-1526
96. Zajonc DM, Ainge GD, Painter GF, Severn WB, Wilson IA (2006) Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d. J Immunol 177:4577-4583
97. Godfrey DI, Rossjohn J (2011) New ways to turn on NKT cells. J Exper Med 208:1121-1125
98. Fujio M, Wu D, Garcia-Navarro R, Ho DD, Tsuji M, Wong CH (2006) Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: Tuning the adjuvant versus immunosuppression activity. J Am Chem Soc 128:9022-9023
99. Park JJ, Lee JH, Ghosh SC, Bricard G, Venkataswamy MM, Porcelli SA, Chung SK (2008) Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand. Bioorg Med Chem Lett 18:3906-3909
100. Russano AM, Agea E, Corazzi L, Postle AD, De Libero G, Porcelli S, de Benedictis FM, Spinozzi F( 2006) Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted gD T cells. J Allergy Clin Immunol 117:1178-1184
101. Tsuji M (2006) Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell Mol Life Sci 63:1889-1898
102. Wojno J, Jukes JP, Ghadbane H, Shepherd D, Besra GS, Cerundolo V, Cox LR (2012) Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production. ACS Chem Biol 7:847-855
103. Wu D, Zajonc DM, Fujio M, Sullivan BA, Kinjo Y, Kronenberg M, Wilson IA, Wong CH (2006) Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A 103:3972-3977
104. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, Koh R, Besra GS, Bharadwaj M, Godfrey DI, McCluskey J, Rossjohn J (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448:44-49
105. Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, Kyparissoudis K, Brooks AG, Reid HH, Gras S, Lucet IS, Koh R, Smyth MJ, Mallevaey T, Matsuda JL, Gapin L, McCluskey J, Godfrey DI, Rossjohn J (2009) Differential recognition of CD1d-A- Galactosyl ceramide by the Vb 8.2 and Vb 7 semiinvariant NKT T cell receptors. Immunity 31:47-59
106. Patel O, Pellicci DG, Uldrich AP, Sullivan LC, Bhati M, McKnight M, Richardson SK, Howell AR, Mallevaey T, Zhang J, Bedel R, Besra GS, Brooks AG, Kjer-Nielsen L, McCluskey J, Porcelli SA, Gapin L, Rossjohn J, Godfrey DI (2011) Vb2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Proc Natl Acad Sci U S A 108:19007-19012
107. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, Sullivan LC, Kyparissoudis K, Kjer-Nielsen L, Vivian JP, Cao B, Brooks AG, Williams SJ, Illarionov P, Besra GS, Turner SJ, Porcelli SA, McCluskey J, Smyth MJ, Rossjohn J, Godfrey DI (2011) A semi-invariant Va101 T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigenrecognition properties. Nat Immunol 12:616-623
108. Scott-Browne JP, Matsuda JL, Mallevaey T, White J, Borg NA, McCluskey J, Rossjohn J, Kappler J, Marrack P, Gapin L (2007) Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 8:1105-1113
109. Wun KS, Borg NA, Kjer-Nielsen L, Beddoe T, Koh R, Richardson SK, Thakur M, Howell AR, Scott-Browne JP, Gapin L, Godfrey DI, McCluskey J, Rossjohn J( 2008) A minimal binding footprint on CD1dglycolipid is a basis for selection of the unique human NKT TCR. J Exper Med 205:939-949
110. Wun KS, Cameron G, Patel O, Pang SS, Pellicci DG, Sullivan LC, Keshipeddy S, Young MH, Uldrich AP, Thakur MS, Richardson SK, Howell AR, Illarionov PA, Brooks AG, Besra GS, McCluskey J, Gapin L, Porcelli SA, Godfrey DI, Rossjohn J (2011) A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34:327-339
111. Mallevaey T, Scott-Browne JP, Matsuda JL, Young MH, Pellicci DG, Patel O, Thakur M, Kjer-Nielsen L, Richardson SK, Cerundolo V, Howell AR, McCluskey J, Godfrey DI, Rossjohn J, Marrack P, Gapin L (2009) T cell receptor CDR2 b and CDR3 b loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31:60-71
112. Mallevaey T, Clarke AJ, Scott-Browne JP, Young MH, Roisman LC, Pellicci DG, Patel O, Vivian JP, Matsuda JL, McCluskey J, Godfrey DI, Marrack P, Rossjohn J, Gapin L (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315-326
113. Gapin L, Godfrey DI, Rossjohn J (2013) Natural killer T cell obsession with self-antigens. Curr Opin Immunol 25:168-173
114. Venkataswamy MM, Porcelli SA (2010) Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 22:68-78
115. Aspeslagh S, Li Y, Yu ED, Pauwels N, Trappeniers M, Girardi E, Decruy T, Van Beneden K, Venken K, Drennan M, Leybaert L, Wang J, Franck RW, Van Calenbergh S, Zajonc DM, Elewaut D (2011) Galactose- modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastatis. EMBO J 30:2294-2305
116. Patel O, Cameron G, Pellicci DG, Liu Z, Byun HS, Beddoe T, McCluskey J, Franck RW, Castano AR, Harrak Y, Llebaria A, Bittman R, Porcelli SA, Godfrey DI, Rossjohn J (2011) NKT TCR recognition of CD1d-a-C-galactosylceramide. J Immunol 187: 4705-4713
117. Wun KS, Ross F, Patel O, Besra GS, Porcelli SA, Richardson SK, Keshipeddy S, Howell AR, Godfrey DI, Rossjohn J (2012) Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex. J Biol Chem 287:39139-39148
118. Li Y, Girardi E, Wang J, Yu ED, Painter GF, Kronenberg M, Zajonc DM (2010) The Va14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exper Med 207:2383-2393
119. Pellicci DG, Clarke AJ, Patel O, Mallevaey T, Beddoe T, Le Nours J, Uldrich AP, McCluskey J, Besra GS, Porcelli SA, Gapin L, Godfrey DI, Rossjohn J (2011) Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol 12:827-833
120. Yu ED, Girardi E, Wang J, Zajonc DM (2011) Cutting edge: Structural basis for the recognition β-linked glycolipid antigens by invariant NKT cells. J Immunol 187:2079-2083
121. Uldrich AP, Le Nours J, Pellicci DG, Gherardin NA, McPherson KG, Lim RT, Patel O, Beddoe T, Gras S, Rossjohn J, Godfrey DI (2013) CD1d-lipid antigen recognition by the gD TCR. Nat Immunol 14:1137-1145
122. Gold MC, Lewinsohn DM (2013) Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rec Micro 11:14-19
123. Birkinshaw RW, Kjer-Nielsen L, Eckle SBG, McCluskey J, Rossjohn J (2014) MAITs, MR1 and vitamin B metabolites. Curr Opin Immunol 26:7-13
124. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, Williamson NA, Purcell AW, Dudek NL, McConville MJ, O?Hair RAJ, Khairallah GN, Godfrey DI, Fairlie DP, Rossjohn J, McCluskey J( 2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491:717-723
125. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z, Eckle SB, Uldrich AP, Birkinshaw RW, Patel O, Kostenko L, Meehan B, Kedzierska K, Liu L, Fairlie DP, Hansen TH, Godfrey DI, Rossjohn J, McCluskey J, Kjer-Nielsen L (2013) Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 210:2305-2320
126. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M, Levy E, Dusseaux M, Meyssonnier V, Premel V, Ngo C, Riteau B, Duban L, Robert D, Huang S, Rottman M, Soudais C, Lantz O (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11:701-708
127. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, Beddoe T, Corbett AJ, Liu L, Miles JJ, Meehan B, Reantragoon R, Sandoval-Romero ML, Sullivan LC, Brooks AG, Chen Z, Fairlie DP, McCluskey J, Rossjohn J (2013) Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun 4:2142
128. Reantragoon R, Kjer-Nielsen L, Patel O, Chen Z, Illing PT, Bhati M, Kostenko L, Bharadwaj M, Meehan B, Hansen TH, Godfrey DI, Rossjohn J, McCluskey J (2012) Structural insight into MR1- mediated recognition of the mucosal associated invariant T cell receptor. J Exper Med 209:761-774
129. López-Sagaseta J, Dulberger CL, Crooks JE, Parks CD, Luoma AM, McFedries A, Van Rhijn I, Saghatelian A, Adams EJ (2013) The molecular basis for mucosal-associated invariant T cell recognition of MR1 proteins. Proc Natl Acad Sci U S A 110:E1771-E1778